Elanco Animal Health Incorporated (ELAN) |
|
30.01 -1.14 (-3.66%)
|
02-24 16:04 |
|
Open: |
30.79 |
Pre. Close: |
31.15 |
|
High:
|
30.9 |
Low:
|
29.655 |
|
Volume:
|
5,921,516 |
Market Cap:
|
11943M |
|
|
|
|
Elanco Animal Health Incorporated, an animal health company, develops, manufactures, and markets products for companion and food animals. The company offers companion animal disease prevention products, such as parasiticide products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications; vaccines, nutritional enzymes, and animal-only antibiotics; and a range of food animal products used in ruminant and swine production. It sells its products to third-party distributors; veterinarians; and food animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated has a research and development collaboration with AgBiome, Inc. to develop nutritional health products for swine. The company |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
30.883 - 31.06 |
31.06 - 31.22 |
|
Low:
|
29.26 - 29.45 |
29.45 - 29.621 |
|
Close:
|
29.736 - 30.041 |
30.041 - 30.317 |
|
Technical analysis |
as of: 2020-02-24 4:42:58 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 36.61  One year: 38.15 |
| Support: |
Support1: 29.21 Support2: 24.30 |
| Resistance: |
Resistance1: 31.34 Resistance2: 32.66 |
| Pivot: |
31.08 |
| Moving Average: |
MA(5): 30.35 MA(20): 31.16
MA(100): 28.39  MA(250): 30.10 |
| MACD: |
MACD(12,26): 0.08 Signal(9): 0.31 |
| Stochastic oscillator: |
%K(14,3): 39.54 %D(3): 32.83 |
| RSI: |
RSI(14): 44.44 |
| 52-week: |
High: 35.46 Low: 25.25 Change(%): 3.3 |
| Average Vol(K): |
3-Month: 502726 10-Days: 489703 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.ELAN has closed above bottom band by 5.8%. Bollinger Bands are 3.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Wed, 19 Feb 2020 19:00:00 +0000
Why Elanco Animal Health's Q4 Results Didn't Have Much Bite
Thu, 06 Feb 2020 09:01:45 +0000
The 9 Best 'Purebred' Pet Stocks to Buy
Mon, 13 Jan 2020 13:32:33 +0000
Elanco Animal Health Signs Deal With PetIQ To Divest Capstar
Thu, 09 Jan 2020 20:17:36 +0000
Notable Thursday Option Activity: SAIL, VSAT, ELAN
Mon, 06 Jan 2020 07:18:48 +0000
Dechra Pharma To Acquire Worldwide Rights To Osurnia From Elanco - Quick Facts
|
Financial Analysis |
| Growth |
NA |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
NA |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
NA |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
NA |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Specialty Generic |
| Shares Out. (M) |
397.98 |
| Shares Float (M) |
372.44 |
|
% Held by Insiders
|
0.25 |
|
% Held by Institutions
|
95.28 |
|
Shares Short (K)
|
13470 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
0.250 |
|
Book Value (p.s.)
|
14.710 |
|
PEG Ratio
|
3.04 |
|
Profit Margin
|
3.04 |
|
Operating Margin
|
13.84 |
|
Return on Assets (ttm)
|
3.0 |
|
Return on Equity (ttm)
|
1.8 |
|
Qtrly Rev. Growth
|
1.3 |
|
Gross Profit (p.s.)
|
3.844 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
1.838 |
|
Qtrly Earnings Growth
|
-83.40 |
|
Operating Cash Flow (M)
|
237.30 |
|
Levered Free Cash Flow (M)
|
267.10 |
Stock Valuations |
|
P/E
|
120.04 |
|
P/E Growth Ratio
|
-0.04 |
|
P/BV
|
2.04 |
|
P/S
|
3.57 |
|
P/CF
|
50.33 |
Dividends & Splits |
|
Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Forward Dividend
|
|
|
Last Split Date
|
|
|
Last Split Ratio
|
-1e+010 |
|
7 Binary Options
|
|
Your Ad Here
|
|
